Edition:
United Kingdom

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

5.73USD
19 Aug 2019
Change (% chg)

-- (--)
Prev Close
$5.73
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
35,186
52-wk High
$12.50
52-wk Low
$3.25

About

AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen... (more)

Overall

Beta: --
Market Cap(Mil.): $639.40
Shares Outstanding(Mil.): 56.77
Dividend: --
Yield (%): --

Financials

  ACIU.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -0.69 -- --
ROI: -32.55 8.94 14.48
ROE: -33.72 10.07 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates